Skip to main content
SpringerLink
Log in

Genetic Counseling and Risk Assessment

  • Chapter
Supportive Cancer Care

  • 928 Accesses

Abstract

Since the early 2000s, improved understanding of the molecular biology of disease has led to the “era of personalized medicine.” Personalized medicine refers to the use of genetic, genomic, and other individual characteristics and exposures to define disease in an individual and to influence treatment and management decisions. With the wealth of genetic information now available, significant advances have been made in the prevention and treatment of many types of cancer, and the interpretation and communication of this information are an important clinical need.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Society of Human Genetics. Genetic counseling. Am J Hum Genet. 1975;27(2):240–2.

    Google Scholar 

  2. NSGC (2014) National Society of Genetic Counselors. Website http://nsgc.org/p/cm/ld/fid=175. Accessed 25 Oct 2014.

  3. Robson ME, et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2010;28(5):803–901.

    Article  Google Scholar 

  4. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol. 2003;21(12):2397–406.

    Article  Google Scholar 

  5. Resta R, et al. A new definition of genetic counseling: National Society of Genetic Counselors’ Task Force report. J Genet Couns. 2006;15(2):77–83.

    Article  PubMed  Google Scholar 

  6. Riley BD, et al. Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns. 2012;21(2):151–61.

    Google Scholar 

  7. Berliner JL, et al. NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer. J Genet Couns. 2013;22(2):155–63.

    Article  PubMed  Google Scholar 

  8. Lancaster JM, et al. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol. 2007;107(2):159–62.

    Article  PubMed  Google Scholar 

  9. American Society of Clinical Oncology. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol. 1996;14(5):1730–6.

    Google Scholar 

  10. Hampel H, et al. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genet Med. 2015;17(1):70–87.

    Article  PubMed  Google Scholar 

  11. Hampel H, et al. Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet. 2004;41(2):81–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Wideroff L, et al. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet. 2005;42(10):749–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Pal T, et al. A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer. Genet Test Mol Biomarkers. 2013;17(5):367–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Lowstuter KJ, et al. Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians. Genet Med. 2008;10(9):691–8.

    Article  PubMed  Google Scholar 

  15. Meyer LA, et al. Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. Obstet Gynecol. 2010;115(5):945–52.

    Article  PubMed  Google Scholar 

  16. Bellcross CA, et al. Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendations for BRCA genetic counseling referral. Cancer Epidemiol Biomarkers Prev. 2013;22(4):728–35.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Wood ME, et al. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative. J Clin Oncol. 2014;32(8):824–9.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Laedtke AL, et al. Family physicians’ awareness and knowledge of the Genetic Information Non-Discrimination Act (GINA). J Genet Couns. 2012;21(2):345–52.

    Article  PubMed  Google Scholar 

  19. Wideroff L, et al. Coherence and completeness of population-based family cancer reports. Cancer Epidemiol Biomarkers Prev. 2010;19(3):799–810.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Mai PL, et al. Confirmation of family cancer history reported in a population-based survey. J Natl Cancer Inst. 2011;103(10):788–97.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Murff HJ, et al. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 2004;292(12):1480–9.

    Article  CAS  PubMed  Google Scholar 

  22. Nelson RM, et al. Ethical issues with genetic testing in pediatrics. Pediatrics. 2001;107(6):1451–5.

    Article  Google Scholar 

  23. American Society of Human Genetics Board of Directors. Points to consider: ethical, legal, and social implications of genetic testing in children and adolescents. Am J Hum Genet. 1995;57(5):1233–41.

    PubMed Central  Google Scholar 

  24. Wertz DC, et al. Genetic testing for children and adolescents. Who decides? JAMA. 1994;272(11):875–81.

    Article  CAS  PubMed  Google Scholar 

  25. Hudson KL, et al. Keeping pace with the times – the Genetic Information Nondiscrimination Act of 2008. N Engl J Med. 2008;358(25):2661–3.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, University of Arizona Cancer Center, 1515 N. Campbell Ave, 245024, Tucson, AZ, 85724, USA

    Joanne M. Jeter MD

Authors
  1. Joanne M. Jeter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joanne M. Jeter MD .

Editor information

Editors and Affiliations

  1. University of Arizona Cancer Center, Tucson, AZ, USA

    David Alberts , Maria Lluria-Prevatt  & Karen Weihs ,  & 

  2. University of Arizona Arizona Cancer Center, Tucson, AZ, USA

    Stephanie Kha

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Jeter, J.M. (2016). Genetic Counseling and Risk Assessment. In: Alberts, D., Lluria-Prevatt, M., Kha, S., Weihs, K. (eds) Supportive Cancer Care. Springer, Cham. https://doi.org/10.1007/978-3-319-24814-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-24814-1_15

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-24812-7

  • Online ISBN: 978-3-319-24814-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation